DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Isoxaprolol
Isoxaprolol
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
(12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
Ovid MEDLINE(R)
Sustained-Release Compositions Containing Cation Exchange Resins and Polycarboxylic Polymers
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Marrakesh Agreement Establishing the World Trade Organization
Multimedia Appendix 1. Search Strategy Developed for Medline Via Ovid to Identify Existing Systematics Review. Concept 1: BP
Customs Tariff - Schedule
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
WHO-EMP-RHT-TSN-2018.1-Eng.Pdf
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Pharmaabkommen A1 E
Top View
Customs Tariff - Schedule Xxi - 1
First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
Tarif Intégré Des Communautés Européennes (TARIC)
Supplementary Information 0103 - 5053 $6.00+0.00 SI in Silico Antibacterial Activity Modeling Based on the TOMOCOMD-CARDD Approach Juan A
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Customs Tariff - Schedule Xxi - 1
Pharmacotherapy for Hypertension in Adults Aged 18 to 59 Years (Review)
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
An Application to Include Blood Pressure Lowering Drug Fixed Dose
United States Patent (19) 11 Patent Number: 5,932,572 Dean Et Al
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) United States Patent (10) Patent No.: US 6,331,289 B1 Klaveness Et Al
Sustained-Release Compositions Containing Cation Exchange Resins and Polycarboxylic Polymers
Identification and Characterization of Antidiabetic And
Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement
E036128.Draft-Revisions.Pdf
Schedule Clxxiii - European Union